The effect of L-carnitine in the treatment of complications of patients with pemphigus vulgaris

Phase 1

• Conditions: pemphigus vulgaris.; Pemphigus vulgaris

• Registration Number: IRCT2015062322769N4
• Lead Sponsor: Vice chancellor for research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

INCLUSION CRITERIA: Willingness to cooperate; Affected by pemphigus vulgaris; Minimum one year of pemphigus vulgaris illness; Using Corticosteroid alone or with one of the Methotrexate, Azathioprine and Cellcept drugs; Age between 30 and 65 years old; BMI<35; Lack of Cardiovascular disease, renal, hepatic and inflammatory intestinal diseases; No alcohol consumption; Do not use of any antioxidant supplementation during the last 3 months; No consumption of Cisplatin, Theophylline and Valproate during the past month; Non-smoking and tobacco use (People who have smoked less than five cigarettes daily in previous 6 months); Lack of pregnancy and lactation
EXCLUSION CRITERIA: Changing the type of used drug; Find allergy symptoms at any time of the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified